Upload
marcus-evans
View
515
Download
1
Embed Size (px)
DESCRIPTION
Dr Daniel L. Mooradian, Innova Medical Design, LLC - Speaker at the marcus evans Medical Device Manufacturing Summit Fall 2012, held in Colorado Springs, delivered his presentation entitled The Impact of Mergers and Acquisitions on R&D Innovation and Productivity
Citation preview
Impact of M&A Activity on R&D Productivity & Innovation
Daniel L. Mooradian, Ph.D. Chief Scientific Officer
Innova Medical Design LLC
Marcus Evans Medical Device Summit 2012 Colorado Springs, CO
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Objectives
• Mechanics of Deal making
• Discuss trends in Medical Device M&A
• Explore the Challenges facing R&D
• Share my experiences (R&D centric) as a “survivor” and student of the subject
• Invite you to share your experiences!
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Introduction
• Mergers & Acquisitions are a necessary and beneficial part of the corporate “life-cycle”
• Small companies - often the preferred strategy to create investor value
• Mid-/Large-Companies - a path to growth via optimization of new or existing sales channels
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Source: www.fiercemedicaldevices.com
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Medical Device M&A Trends
• Strong M&A activity in the Medical Device and Biotech sector through Q2 of 2012
• Modest activity Q3-Q4 2012 based on uncertainty regarding the election outcome, healthcare reform, etc.
• Marketplace seems poised for resurgence in 2013
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Medical Device M&A Trends
• Significant capital on the side-lines – even VCs claim to be eager to invest!
• Trend in large companies away from organic R&D
• Trend in start-ups toward strategic partnership vs. traditional VC route for start-ups
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
The M&A Process
R&D INVOLVEMENT LOW LOW-MEDIUM HIGH
xeon-international.com/services/corporate-finance/ma/the-ma-process
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
M&A Challenges
• Mandatory adoption of cumbersome processes can strain resources
• Reorganization - loss of key management, changes in reporting can impact morale
• Shift in priorities by OPS, Quality, M&S can reduce availability to support product development leading to delay
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Pipeline Value/Technology
• Often an attractive “sweetener” during due diligence.
• The acquired may believe that they will have a new source of support for innovation
• Not the Norm. Cost of acquisition (which comes at the expense of existing businesses) makes it difficult to “double down” before the value of the acquisition itself has been confirmed!
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Strategies to improve R&D integration
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
• Make sure you are represented on the Integration team
• Engage your functional counter-part
• Realize that everyone involved has a “day job”
• Seek opportunities for your Senior staff to participate in key integration activities
• Make integration a priority
Integration Team
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Process Knowledge
• What is your new Innovations Process?
• What is your new company’s Budget Process?
• Who are the key decision-makers?
• Are you adequately represented?
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
The “Deal Model”
• Make sure you understand what constraints have been placed on your current and future budgets as part of the acquirers “deal model”
• If growth in R&D is not built into the deal model then it will be very difficult to grow post-acquisition.
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Next Years Budget
• You new organization is already working on next years budget!
• You are already at a disadvantage
• Learn how budget decisions are made……
• And who makes them!
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Protect Resources
• The deal-model will set limits on unit expenditures post-acquisition
• If your needs are not reflected in the deal-model then you are at a disadvantage
• Pressure on OPS/Manufacturing/Quality (and Clinical) will put existing and future R&D resources at risk
• You must fight for position or risk decline
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Protect Resources
• Critical R&D employees who are not protected by CIC agreements must be identified and protected via retention agreements if possible
• Protect against flight
• Promote engagement
• Reduce uncertainty and anxiety
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Preserve Corporate Culture
• The post-acquisition period is one in which culture can play a critical role in guiding behavior in the face of uncertainty
• Too little emphasis is placed on the integration/assimilation of culture in mergers & acquisitions
• Repeat your core values often to yourself and others.
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Communicate!
New Management Peers
Staff
No news is NOT good news!
Copyright © 2012 Daniel L. Mooradian. All Rights reserved
Thank you!